COVID-19(12) SARS-CoV-2(6) coronavirus(4) off-label(3) pandemic(3) antimalarial(3) cardiovascular risk(3) off-label use(3) variety(3) Rheumatic diseases(3) Hydroxychloroquine(3) Antimalarials(3) crisis(3) widespread(3) Treatment(3) Randomized controlled trials(3) observational studies(3) controlled trials(3) lAbel(3) Hero(3) outcome(3) COVID-19 treatment(3) Evidence(3) investigated(3) coronavirus disease(3) Chloroquine(3) observational study(3) medication(3) Mask(2) NETs(2)